Genmab A (GMAB) Total Liabilities (2023 - 2026)
Genmab A (GMAB) recorded Total Liabilities of $6.56 billion in the quarter ended Jun 30, 2026, down 2.0% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Total Liabilities (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A reported Total Liabilities of $7.03 billion, up 728.6% from the prior year.
- Annual Total Liabilities has increased for three straight years, with a five-year compound annual growth rate of 97.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Total Liabilities came in at $847.99 million in the year ended Dec 31, 2024 (+144.2%), $347.21 million in the year ended Dec 31, 2023 (+31.1%), $264.74 million in the year ended Dec 31, 2022 (-3.6%) and $274.69 million in the year ended Dec 31, 2021 (+16.9%).
- Quarterly Total Liabilities has ranged from $129.26 million in the quarter ended Sep 30, 2025 to $7.03 billion in the quarter ended Dec 31, 2025 over the past five years.
- On a year-over-year basis, Total Liabilities rose in three of the last four quarters, with growth averaging 213.4%.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 728.6% in the quarter ended Dec 31, 2025, against a decline of 98.5% in the quarter ended Sep 30, 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 6.56 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.56 Bn |
| Mar 31, 2026 | 6.69 Bn |
| Dec 31, 2025 | 7.03 Bn |
| Sep 30, 2025 | 129.26 Mn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | 1.28 Bn |
| Dec 31, 2023 | 545.00 Mn |
| Jan 1, 2023 | 406.00 Mn |
API Access
Genmab A Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();